ReviewHuman genomics2025
From bulk RNA sequencing to spatial transcriptomics: a comparative review of differential gene expression analysis methods.
Review in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Article
- Identification of Hub Gene Characteristics and Immune Landscapes Across Aging Subtypes in Atherosclerosis: A Machine Learning-Based Multi-Omics Study With Experimental Verification.Chemical biology & drug design · 2026Article
- RNA Sequencing Technologies in Acute Lymphoblastic Leukemia: A Comparative Technical Review.Current issues in molecular biology · 2026Review
- Assessment of the role of inflammation-linked signaling pathways in ventilator-induced diaphragmatic dysfunction in rats by transcriptome RNA-seq.BMC molecular and cell biology · 2026Article
- Spatial Transcriptomic Profiling Reveals Microenvironment-Dependent Immune Signatures in a Lyme Arthritis model.bioRxiv : the preprint server for biology · 2026Article
- Transcriptome Profiling of Leaves and Roots from Rooibos (Plants (Basel, Switzerland) · 2026Article
- Identification of ATF3 as a Potential Key Biomarker for Hypertensive Nephropathy via Single-Cell Transcriptome Sequencing.Inflammation · 2026Article
- MatriSpace: Identification and visualization of spatially resolved ECM gene expression patterns in health and disease.bioRxiv : the preprint server for biology · 2026Article
- Circular RNAs in Plasma and Beyond: Potential Biomarkers for Breast Cancer.Oncology research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranscriptome analysis is essential to dissect the molecular mechanisms underlying phenotypic differences and disease mechanisms. Traditionally, microarrays were used, but RNA sequencing (RNA-seq) has become a more powerful and reproducible alternative. RNA-seq is widely applied for differential expression analysis (DEA) analysis, making it possible to characterize gene expression heterogeneity across diverse biological conditions. MAIN BODY: Several approaches are used in RNA-seq, including bulk RNA-seq, single-cell RNA sequencing (scRNA-seq), direct RNA sequencing (DRS), and spatial transcriptomics (ST), every distinct offering unique insight. Bulk RNA-seq offers a global perspective on transcriptional activity, while scRNA-seq dissects the intrinsic cellular diversity and developmental trajectories, aiding for delineating molecular profiles of low-abundance cell phenotypes and complex biology. However, both methods face challenges such as biases from short-read sequencing, limited isoform resolution, and the loss of spatial information. Advanced methods such as DRS and ST have emerged to address these limitations. RNA-seq data analysis comprises a multi-phase workflow, including read trimming, alignment, quantification, normalization, and differential expression testing. As sequencing technologies evolve, numerous computational tools and statistical methods have been developed to support DEA across bulk, scRNA-seq, DRS, and ST datasets, enhancing our ability to interpret transcriptomic changes in health and disease. Applications of RNA-seq include interrogation of multifactorial disease mechanisms, biomarker discovery, and the investigation of gene regulatory networks.
conclusionExamining gene expression through these diverse RNA-seq modalities deepens our understanding of cellular processes, transcript modifications, tissue spatial organization, and gene expression variability. This review highlights current DEA methods in R and Python for bulk RNA-seq, scRNA-seq, DRS, and ST, showcasing the rapidly evolving landscape of transcriptome research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.